The Scientist

» E. coli and disease/medicine

Most Recent

image: Pleasant to the Touch

Pleasant to the Touch

By | September 1, 2012

Scientists hope an understanding of nerve fibers responsive only to gentle touch will give insight into the role the sense plays in social bonding.


image: Opinion: Younger Is Better

Opinion: Younger Is Better

By | August 31, 2012

Stem cells collected from younger donors are more effective for transplantation and regenerative medicine than those from older individuals.


image: Dieting Monkeys Don't Live Longer

Dieting Monkeys Don't Live Longer

By | August 29, 2012

The latest news from a long-term study of calorie restriction in rhesus macaques shows better health, but no boost in lifespan, in monkeys who eat less.


image: Epigenetic Drug Improves Cholesterol Levels

Epigenetic Drug Improves Cholesterol Levels

By | August 28, 2012

Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.

1 Comment

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

image: Second Victim of Hantavirus

Second Victim of Hantavirus

By | August 28, 2012

Another person has died from the rodent-borne disease after visiting Yosemite National Park.


image: Texan West Nile Concerns

Texan West Nile Concerns

By | August 27, 2012

Researchers consider the recent reappearance of West Nile virus in Texas and the efforts to control it.


image: Blood Spots Are Epigenetic Time Capsules

Blood Spots Are Epigenetic Time Capsules

By | August 22, 2012

Researchers show that blood spotted onto Guthrie cards, usually at birth, can be a high quality source of methylated DNA for long-term epigenetic studies.


image: Zoo Virus Swap

Zoo Virus Swap

By | August 17, 2012

A polar bear in a German zoo dies after contracting a virus normally found in zebras.


image: Pharma Whistleblower

Pharma Whistleblower

By | August 16, 2012

A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.

1 Comment

Popular Now

  1. Antidepressant Exerts Epigenetic Changes
  2. Inside a Lab Mouse’s High-Fat Diet
  3. Image of the Day: Mother’s Love
  4. Remote Mind Control
Life Technologies